Rights and permissions
About this article
Cite this article
‘Cozaar’ more costly than Merck’s ACE inhibitors. Inpharma Wkly. 985, 22 (1995). https://doi.org/10.2165/00128413-199509850-00052
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199509850-00052